Colorectal cancer screening at age 45 years in Israel: Cost‐effectiveness and global implications
Cancer · 2024
DOI: 10.1002/cncr.35097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2024. Verfasst von Elizabeth E Half und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Institute, Rambam Health Care Campus, Haifa, Israel. Hauptthemen laut MEDLINE: Early Detection of Cancer, Colorectal Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Background Colorectal cancer (CRC) incidence at ages
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology Institute, Rambam Health Care Campus, Haifa, Israel.
- The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
- Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Division of Gastroenterology and Hepatology, Department of Medicine, Stanford School of Medicine, Stanford University, Stanford, California, USA.
- Coller School of Management, Tel Aviv University, Tel Aviv, Israel.
ORCID-Profile: Elizabeth E Half, Zohar Levi, Uri Ladabaum
Zitieren
APA
Half, E. E., Levi, Z., Mannalithara, A., Leshno, M., Ben-Aharon, I., Abu-Freha, N., Silverman, B., & Ladabaum, U. (2024). Colorectal cancer screening at age 45 years in Israel: Cost‐effectiveness and global implications. Cancer. https://doi.org/10.1002/cncr.35097
Vancouver
Half EE, Levi Z, Mannalithara A, Leshno M, Ben-Aharon I, Abu-Freha N, et al. Colorectal cancer screening at age 45 years in Israel: Cost‐effectiveness and global implications. Cancer. 2024. doi:10.1002/cncr.35097
BibTeX
@article{Half2024,
author = {Half, Elizabeth E and Levi, Zohar and Mannalithara, Ajitha and Leshno, Moshe and Ben-Aharon, Irit and Abu-Freha, Naim and Silverman, Barbara and Ladabaum, Uri},
title = {Colorectal cancer screening at age 45 years in Israel: Cost‐effectiveness and global implications},
journal = {Cancer},
year = {2024},
doi = {10.1002/cncr.35097}
}
EUVIMED